On August 5, 2021, Genomictree Inc. (KOSDAQ:A228760) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21,200 KRW | +0.24% | -5.15% | +2.91% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.91% | 370M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp.